Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

Clinical trial NCT06896110 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06896110
Sponsor: Andrew P. Groves
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma (GBM)Diffuse Midline Glioma (DMG)Astrocytoma, IDH-Mutant, Grade 4 Diffuse Hemispheric Glioma, H3 G34-Mutant Gliosarcoma of Brain

Start date: 2025-06-05
Primary completion: 2027-03-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.